Harvard medical school and ISK Ltd submitted a grant application for a clinical trial with Alzheimer’s patientsApril 13, 2021
ISK Ltd and Harvard medical school submitted together grant application to support phase 1B clinical trial for treatment of Alzheimer’s disease.